Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biodexa Pharmaceuticals plc - American Depositary Shares
(NQ:
BDRX
)
6.225
-0.435 (-6.53%)
Streaming Delayed Price
Updated: 3:07 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biodexa Pharmaceuticals plc - American Depositary Shares
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
October 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
October 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
October 17, 2024
Via
ACCESSWIRE
Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition
May 09, 2024
Via
ACCESSWIRE
Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers
March 28, 2024
Via
ACCESSWIRE
Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone
March 01, 2024
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equity
April 20, 2023
Via
ACCESSWIRE
Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data
July 11, 2024
Via
ACCESSWIRE
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
June 03, 2024
Via
ACCESSWIRE
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End
August 09, 2023
EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equity
April 11, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equity
April 06, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equity
April 05, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equity
April 04, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Issue of Pre-Funded Warrants
April 03, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
March 30, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
March 29, 2023
Via
ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
March 28, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.